Retinoblastoma and phosphate and tensin homolog tumor suppressors: impact on ductal carcinoma in situ progression
about
Retinoblastoma tumor suppressor pathway in breast cancer: prognosis, precision medicine, and therapeutic interventionsMulti-gene fluorescence in situ hybridization to detect cell cycle gene copy number aberrations in young breast cancer patients.Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis.The retinoblastoma tumor suppressor pathway modulates the invasiveness of ErbB2-positive breast cancer.Carcinoma initiation via RB tumor suppressor inactivation: a versatile approach to epithelial subtype-dependent cancer initiation in diverse tissues.RB loss contributes to aggressive tumor phenotypes in MYC-driven triple negative breast cancer.Partial PTEN deletion is linked to poor prognosis in breast cancerFocusing on breast cancer overdiagnosis and overtreatment: the promise of molecular medicine.Stromal architecture and periductal decorin are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinoma in situ of the breast.Histopathological characterization of ductal carcinoma in situ (DCIS) of the breast according to HER2 amplification status and molecular subtype.HPV Status and Its Correlation with BCL2, p21, p53, Rb, and Survivin Expression in Breast Cancer in a Chinese Population.Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer.
P2860
Q27022834-86F8BEAB-94AA-4F9C-B4AD-A53997B9BEE6Q33728390-FC29583B-3331-431A-ADC6-C4D699B9B018Q33762003-C81B53F5-7CF1-4E87-94CF-BA6A0618372FQ34115095-27B268C6-2CA1-49AD-830E-6D7FB79A63B0Q35061054-C4C0DE5B-B011-4705-B0FE-501FB0E68662Q35157633-EF8451E3-B033-4C2F-A213-EB571C614AF4Q35870069-C608E48D-6A71-4EEA-B04B-684A43345AE6Q43483166-9DF08539-97D8-4040-B4D1-C97B0222DE0BQ45393620-5D70EDF1-D5D7-4962-A692-35E9A2DF2C8BQ49061414-FF5BE9CC-83B9-46B6-8924-7712EBAEE3CFQ49199308-6B975DFC-ACE3-4D26-922E-279C11FF7FD8Q49547342-C096C6E5-BCBB-49FC-942D-9C78417CD988
P2860
Retinoblastoma and phosphate and tensin homolog tumor suppressors: impact on ductal carcinoma in situ progression
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Retinoblastoma and phosphate a ...... carcinoma in situ progression
@ast
Retinoblastoma and phosphate a ...... carcinoma in situ progression
@en
type
label
Retinoblastoma and phosphate a ...... carcinoma in situ progression
@ast
Retinoblastoma and phosphate a ...... carcinoma in situ progression
@en
prefLabel
Retinoblastoma and phosphate a ...... carcinoma in situ progression
@ast
Retinoblastoma and phosphate a ...... carcinoma in situ progression
@en
P2093
P2860
P356
P1476
Retinoblastoma and phosphate a ...... carcinoma in situ progression
@en
P2093
A Kathleen McClendon
Agnieszka K Witkiewicz
Benjamin D Armon
Erik S Knudsen
Gordon F Schwartz
Maria Qeenan
Thomas F Pajak
P2860
P304
P356
10.1093/JNCI/DJS446
P407
P577
2012-11-28T00:00:00Z